Clinical Trial Update: Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating indocyanine green fluorescence imaging with a radioisotope method for sentinel lymph node biopsy in breast cancer patients. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2018-04-09